Somayeh Pouyanfard

Title: Somayeh Pouyanfard: Innovator in HPV Immunogenicity

Introduction

Somayeh Pouyanfard is a notable inventor based in Heidelberg, Germany. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human papillomavirus (HPV). Her work is crucial in the ongoing fight against HPV-related diseases.

Latest Patents

Somayeh Pouyanfard holds a patent for an immunogenic polypeptide that comprises a multitude of HPV L2 N-terminal peptides. This invention specifically targets amino acids 20 to 50 of the L2 polypeptide of HPV16. The polypeptide is designed for use in medicine and vaccination against HPV infection. Additionally, her patent includes a polynucleotide encoding the immunogenic polypeptide and a host cell that contains it. The invention also encompasses kits, methods, and various uses related to the immunogenic polypeptide.

Career Highlights

Somayeh is affiliated with the Deutsches Krebsforschungszentrum, where she continues her research and development efforts. Her innovative work has the potential to impact public health significantly by providing new avenues for HPV vaccination and treatment.

Collaborations

Somayeh has collaborated with esteemed colleagues such as Angelo Bolchi and Martin Müller. These partnerships enhance the research and development of her innovative projects.

Conclusion

Somayeh Pouyanfard is a pioneering inventor whose work in HPV immunogenicity is paving the way for advancements in medical science. Her contributions are vital in the ongoing efforts to combat HPV infections and improve public health outcomes.